Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.764 USD | -0.77% | +24.19% | +126.34% |
05-24 | Monopar Therapeutics Names Karthik Radhakrishnan as CFO | MT |
05-24 | Monopar Therapeutics Inc. Announces CFO Changes | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+126.34% | 13.44M | |
+45.76% | 56.65B | |
-6.92% | 39.44B | |
+39.19% | 39.03B | |
-6.65% | 26.86B | |
+12.40% | 26.75B | |
-21.24% | 19.03B | |
+0.89% | 12.28B | |
+24.63% | 12.26B | |
+27.25% | 12.04B |
- Stock Market
- Equities
- MNPR Stock
- News Monopar Therapeutics Inc.
- Roth Capital Reinstates Monopar Therapeutics at Buy With $18 Price Target